BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2022 7:20:14 AM | Browse: 619 | Download: 2103
Publication Name World Journal of Clinical Cases
Manuscript ID 79327
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See https://creativecommons.org/Licenses/by-nc/4.0/.
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Shu-Peng Zou, Qian Cheng, Cheng-Yang Feng, Chan Xu and Ming-Hui Sun
ORCID
Author(s) ORCID Number
Ming-Hui Sun http://orcid.org/0000-0003-3545-5411
Funding Agency and Grant Number
Corresponding Author Ming-Hui Sun, MD, PhD, Pharmacist, Professor, Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1037 Luoyu Road, Wuhan 430000, Hubei Province, China. tjzoushupeng@163.com
Key Words Helicobacter pylori; Clarithromycin resistance; First-line therapy; Proton pump inhibitors
Core Tip This is the first study to compare currently available first-line treatment regimens for eradication of antibiotic-resistant Helicobacter pylori strains. For clarithromycin-resistant and metronidazole-resistant strains, dual therapy containing a high-dose proton pump inhibitor (HDDT) shows an absolute advantage over other first-line therapies. There was a difference in the effectiveness of HDDT between all patients and patients with clarithromycin-resistant Helicobacter pylori infection. In the subgroup of high cure rates (≥ 90%), HDDT was also generally better than other therapies. The use of fewer antibiotics may be better to prevent global antibiotic resistance effectively.
Publish Date 2022-12-14 07:20
Citation Zou SP, Cheng Q, Feng CY, Xu C, Sun MH. Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis. World J Clin Cases 2022; 10(35): 12959-12970
URL https://www.wjgnet.com/2307-8960/full/v10/i35/12959.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i35.12959
Full Article (PDF) WJCC-10-12959.pdf
Full Article (Word) WJCC-10-12959.docx